E-LIB Suche - Ergebnisse für: Prat Aparicio, Aleix

1

Positioning of tucatinib in the new clinical scenario of HE..:

Conte, Pierfranco ; Ciruelos, Eva ; Curigliano, Giuseppe...
The Breast. 76 (2024) - p. 103742 , 2024

Link: https://doi.org/10.1016/..

2

HER2DX Genomic Assay in HER2-positive Early Breast Cancer T..:

Llombart-Cussac, Antonio ; Pérez-García, José ; Brasó-Maristany, Fara...
Clinical Cancer Research. , 2024

Link: https://doi.org/10.1158/..

3

Hormone receptor-positive early breast cancer in young wome..:

Walbaum, Benjamin ; García-Fructuoso, Isabel ; Martínez-Sáez, Olga...
Cancer Treatment Reviews. , 2024

Link: https://doi.org/10.1016/..

4

Comparative biological activity of palbociclib and ribocicl..:

Lorman-Carbó, Natàlia ; Martínez-Sáez, Olga ; Fernandez-Martinez, Aranzazu...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

5

Previous immune checkpoint inhibitor therapy is associated ..:

Mostaghim, Anahita ; Minkove, Samuel ; Aguilar-Company, Juan...
International Journal of Infectious Diseases. 139 (2024) - p. 13-20 , 2024

Link: https://doi.org/10.1016/..

6

3-year invasive disease-free survival with chemotherapy de-..:

Pérez-García, José Manuel ; Cortés, Javier ; Ruiz-Borrego, Manuel...
The Lancet. 403 (2024) 10437 - p. 1649-1659 , 2024

Link: https://doi.org/10.1016/..

7

A 14-gene B-cell immune signature in early-stage triple-neg..:

Conte, Benedetta ; Brasó-Maristany, Fara ; Hernández, Adela Rodríguez...
eBioMedicine. 102 (2024) - p. 105043 , 2024

Link: https://doi.org/10.1016/..

8

Management of early-stage HER2-positive breast cancer and a..:

Martínez-Sáez, Olga ; Cortés, Javier ; Ciruelos, Eva...
Clinical and Translational Oncology. 26 (2024) 8 - p. 2060-2069 , 2024

Link: https://doi.org/10.1007/..

9

Clinicopathological and molecular predictors of [18F]FDG-PE..:

Llombart-Cussac, Antonio ; Prat, Aleix ; Pérez-García, José Manuel...
European Journal of Nuclear Medicine and Molecular Imaging. 51 (2024) 9 - p. 2733-2743 , 2024

Link: https://doi.org/10.1007/..

10

The evolving landscape of metastatic HER2-positive, hormone..:

Boscolo Bielo, Luca ; Trapani, Dario ; Nicolò, Eleonora...
Cancer Treatment Reviews. 128 (2024) - p. 102761 , 2024

Link: https://doi.org/10.1016/..

11

Characterisation and Outcomes of Patients with Solid Organ ..:

García de Herreros, Marta ; Laguna, Juan Carlos ; Padrosa, Joan...
Diagnostics. 14 (2024) 7 - p. 730 , 2024

Link: https://doi.org/10.3390/..

12

Cell-cycle inhibition and immune microenvironment in breast..:

Pascual, Tomás ; Fernandez-Martinez, Aranzazu ; Agrawal, Yash...
npj Breast Cancer. 10 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

13

CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-..:

Schettini, Francesco ; Palleschi, Michela ; Mannozzi, Francesca...
The Oncologist. 29 (2024) 5 - p. e622-e634 , 2024

Link: https://doi.org/10.1093/..

14

Impact of SARS-CoV-2 vaccines and recent chemotherapy on CO..:

Vincenzi, Bruno ; Cortellini, Alessio ; Mazzocca, Alessandro...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

15

CAR affinity modulates the sensitivity of CAR-T cells to PD..:

Andreu-Saumell, Irene ; Rodriguez-Garcia, Alba ; Mühlgrabner, Vanessa...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..